Sheel Biotech (NSE:SHEEL) Long-Term Debt: ₹12 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
18 GF Score
Price ₹65.10
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech Long-Term Debt?

Sheel Biotech NSE:SHEEL 18 Long-Term Debt is ₹12 Mil as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Sheel Biotech's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹12 Mil.

Sheel Biotech's quarterly Long-Term Debt declined from Mar. 2024 (₹103 Mil) to Mar. 2025 (₹48 Mil) and declined from Mar. 2025 (₹48 Mil) to Mar. 2026 (₹12 Mil).

Sheel Biotech's annual Long-Term Debt declined from Mar. 2024 (₹103 Mil) to Mar. 2025 (₹48 Mil) and declined from Mar. 2025 (₹48 Mil) to Mar. 2026 (₹12 Mil).

Sheel Biotech  (NSE:SHEEL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sheel Biotech Long-Term Debt Related Terms

Sheel Biotech Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech Long-Term Debt Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
133.84 94.41 102.68 48.23 12.44

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt 133.84 94.41 102.68 48.23 12.44
NSE:SHEEL
18GF Score
Sheel Biotech Ltd NSE:SHEEL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹12 Mil mean?
Sheel Biotech (NSE:SHEEL) has a Long-Term Debt of ₹12 Mil as of Mar. 2026.
Is Sheel Biotech's Long-Term Debt too high?
Sheel Biotech's current Long-Term Debt is ₹12 Mil. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Long-Term Debt compare to ADM and BG?
Sheel Biotech's Long-Term Debt of ₹12 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Consumer Packaged Goods company?
A good Long-Term Debt depends on the Consumer Packaged Goods industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Sheel Biotech's current Long-Term Debt is ₹12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Long-Term Debt of ₹12 Mil. The current Long-Term Debt is ₹12 Mil. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Long-Term Debt is ₹12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score

Get the complete analysis for NSE:SHEEL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹65.10
Price